Tizanidine Hydrochloride
Product Images NDC 68387-130

6 FDA label images from Keltman Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 68387-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Keltman Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mean Tizanidine Concentration Vs. Time Profiles (hours) (Tizanidine Figure 01)

Mean Tizanidine Concentration Vs. Time Profiles (hours) (Tizanidine Figure 01)
A line graph depicting plasma tizanidine concentration (ng/mL) over time (hours) from dosing. It compares 4 mg tizanidine tablets and capsules under conditions of with food and without food, showing concentration changes from 0 to 24 hours post-dose.*
FDA Label Image

Single-dose Study (Tizanidine Figure 02)

Single-dose Study (Tizanidine Figure 02)
A line graph showing improvement in Ashworth Score over 6 hours post-dose. The graph compares three groups: placebo, 8 mg tizanidine, and 16 mg tizanidine. Both tizanidine doses show greater improvement compared to placebo, with 16 mg showing the highest score peak around 2 hours post-dose, followed by gradual decline.*
FDA Label Image

Multiple-dose Study (Tizanidine Figure 03)

Multiple-dose Study (Tizanidine Figure 03)
A line graph displaying the improvement in Ashworth Score for Tizanidine (mean dose 28.8 mg) versus placebo across three time points: end of titration (week 3), end of maintenance (week 7), and endpoint (last observation carried forward). The graph shows mean scores with error bars for each group at all time points.*
FDA Label Image

Label Image For 4mg (Tizanidine Image 4mg)

Label Image For 4mg (Tizanidine Image 4mg)
Label for Tizanidine HCL 4 mg tablets, generic Zanaflex, containing 90 tablets. The label shows dosage strength, storage instructions, lot number PE880B1, and expiration date 5/2011. Manufactured by Coperpharma LLC and distributed by Keltman Pharmaceuticals Inc.*
FDA Label Image

Structural Formula (Tizanidine Structure)

Structural Formula (Tizanidine Structure)
Chemical structure of Tizanidine Hydrochloride shows the molecular arrangement including a chlorinated thiazole ring and imidazoline ring as part of the active compound.*
FDA Label Image

Label Image For 2mg (Tizanidine Image 2mg)

Label Image For 2mg (Tizanidine Image 2mg)
Label for Tizanidine HCL 2mg tablets, generic Zanaflex, from Keltman Pharmaceuticals Inc. The label states the package contains 90 tablets, each with 2.288mg tizanidine HCL equivalent to 2mg tizanidine base. It includes lot number CPC7831 and expiration date 3/2010. Additional details include storage instructions, caution, and manufacturing and distribution information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.